2023-2024 Regular Session • New York Legislature
A08395
Legislative Summary
Adds xylazine to the depressants designated as controlled substances with the exception of use in cattle or other nonhuman species if approved by the federal food and drug administration.
Demographic Impact
Overall analysis of equity impact
60% Positive
Medium ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
12/13/2023
referred to health
Assembly
1/3/2024
referred to health
Assembly
2/8/2024
amend and recommit to health
Assembly
2/8/2024
print number 8395a
Assembly
7/3/2024
amend and recommit to health
Assembly
7/3/2024
print number 8395b
Assembly
Status Information
Current Status
Introduced(12/13/2023)
Chamber
Assembly
Committee
Health(Assembly)
Sponsors
Democrat: 19
Republican: 14
Primary Sponsor
Steve Stern
Democrat
Co-Sponsors (32)
Fred Thiele
Democrat
Charles Lavine
Democrat
Kimberly Jean-Pierre
Democrat
Jo Simon
Democrat
Keith Brown
Republican
Eric Brown
Republican
Joseph DeStefano
Republican
Jarett Gandolfo
Republican
Jacob Blumencranz
Republican
Lester Chang
Republican
Michael Durso
Republican
Edward Flood
Republican
David McDonough
Republican
Kenneth Blankenbush
Republican
Scott Gray
Republican
Matthew Slater
Republican
Scott Bendett
Republican
Jennifer Lunsford
Democrat
John McDonald
Democrat
William Colton
Democrat
Marianne Buttenschon
Democrat
Stacey Pheffer Amato
Democrat
D. Billy Jones
Democrat
William Conrad
Democrat
Charles Fall
Democrat
Angelo Santabarbara
Democrat
Monica Wallace
Democrat
Albert Stirpe
Democrat
Jaime Williams
Democrat
Edward Ra
Republican
Gina Sillitti
Democrat
Maryjane Shimsky
Democrat